PAX5 modulates vascularization and contributes to neuroendocrine lineage transition during carcinoma progression
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci190596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Ailing Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal Univer…. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, PAX5 Transcription Factor, Cell Lineage, Carcinoma, Neuroendocrine. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, the National Natural Science Foundation of China, the Interdisciplinary Research Project of Hangzhou Normal University.
Abstract (Originalsprache)
Human carcinomas often gain aggressive characteristics and escape cell type–specific treatment regimens through cryptic shifts in lineage states. However, the underlying mechanisms that govern lineage plasticity in carcinomas are undefined. Here in this study, we found that PAX5 , a neural/lymphatic transcription factor, contributed to neuroendocrine (NE) lineage transition. PAX5 was highly expressed in aggressive human NE carcinoma cells and tissues but not in non-NE cancer cells and tissues. Deletion of Pax5 in Rb1 fl/fl Trp53 fl/fl mice caused a reduction of tumor vessels, loss of NE morphologic features, and decreased expression of ASCL1, NCAM, and SYP, whereas ectopic expression of PAX5 in CC10-rtTA TetO- hEGFR ex19del/T790M mouse adenocarcinomas and in LNCAP prostate cancer xenografts induced an angiogenic microenvironment and NE morphology. Importantly, antiangiogenic drugs reduced NE features of Rb1 fl/fl Trp53 fl/fl tumors and blocked PAX5 -induced NE transformation. These studies demonstrate an essential role of an angiogenic microenvironment in transition/maintenance of NE lineage, suggesting that targeting PAX5 and its downstream signaling may modulate lineage transitions responsible for treatment failure in both small cell neuroendocrine carcinoma and adenocarcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.
- Department of Pathology, Tianjin First Center Hospital, Tianjin, China.
- Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
- Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Tianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin, China.
- Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Förderung
- NCI NIH HHS
- the National Natural Science Foundation of China
- the Interdisciplinary Research Project of Hangzhou Normal University
- the National Institutes of Health
- the Cancer Prevention and Research Institute of Texas
Zitieren
APA
Wu, A., Hao, Y., Yan, X., Liu, J., Wang, L., Jin, Y., Liu, W., Chen, X., Jiang, Y., Girard, L., Shang, Z., Yan, J., Zhang, Z., Gong, W., Niu, Y., Drapkin, B. J., Minna, J. D., Terada, L. S., Ma, Z., & Liu, Z. (2026). PAX5 modulates vascularization and contributes to neuroendocrine lineage transition during carcinoma progression. Journal of Clinical Investigation. https://doi.org/10.1172/jci190596
Vancouver
Wu A, Hao Y, Yan X, Liu J, Wang L, Jin Y, et al. PAX5 modulates vascularization and contributes to neuroendocrine lineage transition during carcinoma progression. Journal of Clinical Investigation. 2026. doi:10.1172/jci190596
BibTeX
@article{Wu2026,
author = {Wu, Ailing and Hao, Yujie and Yan, Xuemiao and Liu, Junrong and Wang, Lin and Jin, Yan and Liu, Wenxu and Chen, Xiyue and Jiang, Yuan and Girard, Luc and Shang, Zhiqun and Yan, Jun and Zhang, Zhenfa and Gong, Wenchen and Niu, Yuanjie and Drapkin, Benjamin J and Minna, John D and Terada, Lance S and Ma, Zhenyi and Liu, Zhe},
title = {PAX5 modulates vascularization and contributes to neuroendocrine lineage transition during carcinoma progression},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci190596}
}
EUVIMED